Blocking tumor necrosis factor paved the way for targeted therapeutics in inflammatory diseases

作     者：Cong-Qiu Chu Cong-Qiu Chu

作者机构：Division of Arthritis and Rheumatic DiseasesOregon Health&Science University and Rheumatology SectionVA Portland Health Care SystemPortlandOR 97239USA 

出 版 物：《Chinese Medical Journal》 (中华医学杂志（英文版）)

年 卷 期：2021年第134卷第21期

页      面：2525-2528页

核心收录：

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：Dr.Chu’s work was supported by an Innovative Award from American College of Rheumatology Research Foundation and by a VA Merit Review grant(No.I01BX005195)。 

主　　题：inflammatory diseases targeted 

摘      要：Tumor necrosis factor(TNF)becomes a well-known name largely owing to the success of its antagonists in therapy of inflammatory diseases.[1,2]In 1975,in searching for cancer therapeutic agent.